Total | Prior-users | Never-users | P value | |
---|---|---|---|---|
N= 86 (100%) | n= 19 (19%) | n= 67 (81%) | ||
Demographics | ||||
Age (Mean, SD) | 80 (±10.3) | 79 (±5.2) | 80 (±11.3) | 0.77 |
Female | 77 (89.5%) | 15 (78.9%) | 62 (92.5%) (Mean, SD) | 0.09 |
Race | 0.64 | |||
White, non-Hispanic | 83 (96.5%) | 16 (94.7%) | 64 (95.5%) | |
Black, non-Hispanic | 3 (3.5%) | 1 (5.3%) | 2 (3.0%) | |
Education | 0.77 | |||
Less than 8th grade | 10 (11.6%) | 3 (15.8%) | 7 (10.4%) | |
Some high school | 15 (17.4%) | 4 (21.1%) | 11 (16.4%) | |
High school graduate | 44 (51.2%) | 8 (42.1%) | 36 (53.7%) | |
Some college or greater | 15 (17.4%) | 4 (21.1%) | 11 (16.4%) | |
Unknown | 2 (2.3%) | 0 (0.0%) | 2 (3.0%) | |
Income | 0.59 | |||
Below $25,000 | 82 (95.3%) | 19 (100%) | 63 (94.0%) | |
Above $25,000 | 1 (1.2%) | 0 (0.0%) | 1 (1.5%) | |
Unknown | 3 (3.5%) | 0 (0.0%) | 3 (4.5%) | |
RA characteristics | ||||
Morning stiffness | 63 (73.3%) | 17 (89.5%) | 46 (68.7%) | 0.07 |
Nodules around elbow/ankle | 13 (15.1%) | 3 (15.8%) | 10 (14.9%) | 0.93 |
Self-reported swollen joints | 0.06 | |||
Zero | 28 (32.6%) | 4 (21.1%) | 24 (34.8%) | |
One | 5 (5.8%) | 1 (5.3%) | 4 (6.0%) | |
Two | 21 (24.4%) | 3 (15.8%) | 18 (26.9%) | |
Three | 10 (11.6%) | 3 (15.8%) | 7 (10.4%) | |
Four or more | 22 (25.6%) | 8 (42.1%) | 15 (20.9%) | |
Self-reported serologic status | 50 (58.1%) | 16 (84.2%) | 34 (50.7%) | 0.06 |
Positive | 21 (24.4%) | 10 (52.6%) | 11 (16.4%) | |
Negative | 2 (2.3%) | 1 (5.3%) | 1 (1.5%) | |
Do not know | 25 (29.1%) | 4 (21.1%) | 21 (31.3%) | |
Years with RA (mean, SD) | 20 ± 15.9 | 25 ± 17.6 | 18 ±15.2 | 0.13 |
MHAQ (mean, SD) | 0.5 ± 0.5 | 0.8 ± 0.6 | 0.5 ± 0.5 | 0.02 |
0 | 18 (20.9%) | 1 (5.3%) | 19 (28.4%) | 0.01 |
>0-1 | 53 (61.6%) | 12 (63.2%) | 41 (61.2%) | |
>1-2 | 11 (12.8%) | 5 (26.3%) | 6 (9.0%) | |
>2-3 | 2 (2.3%) | 1 (5.3%) | 1 (1.5%) | |
Prior visit with rheum >1 year ago | 39 (45.3%) | 15 (78.9%) | 27 (35.8%) | 0.01 |